These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 18183009)

  • 41. Biotech knowledge trust.
    Wilan KH
    Nat Biotechnol; 2005 Aug; 23(8):921-3. PubMed ID: 16114122
    [No Abstract]   [Full Text] [Related]  

  • 42. State of biotech sector--2005.
    Lawrence S
    Nat Biotechnol; 2006 Jun; 24(6):603. PubMed ID: 16763577
    [No Abstract]   [Full Text] [Related]  

  • 43. SusChem industrial biotechnology--potentials and challenges in industrial biotech in Europe.
    Burel C
    ChemSusChem; 2008; 1(8-9):773-4. PubMed ID: 18686284
    [No Abstract]   [Full Text] [Related]  

  • 44. Parallel biopolitical universes.
    Morris SH
    Nat Biotechnol; 2007 Jan; 25(1):33-4. PubMed ID: 17211389
    [No Abstract]   [Full Text] [Related]  

  • 45. BTJ Forum: Biotech in the financial crisis.
    Biotechnol J; 2009 Aug; 4(8):1108-10. PubMed ID: 19685461
    [No Abstract]   [Full Text] [Related]  

  • 46. Patent holdings of US biotherapeutic companies in major markets.
    Sebastian TE; Yerram CB; Saberwal G
    Drug Discov Today; 2009 May; 14(9-10):442-5. PubMed ID: 19429502
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Biotechnology in South Africa.
    Cloete TE; Nel LH; Theron J
    Trends Biotechnol; 2006 Dec; 24(12):557-62. PubMed ID: 17070947
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Biotech regulation in India: problems and promises.
    Reddy KI
    Biotechnol J; 2009 Mar; 4(3):306-9. PubMed ID: 19296437
    [No Abstract]   [Full Text] [Related]  

  • 49. Biotechnology and science policy.
    Moses V
    Curr Opin Biotechnol; 2004 Jun; 15(3):237-40. PubMed ID: 15193332
    [No Abstract]   [Full Text] [Related]  

  • 50. Open source and biotech.
    Bains W
    Nat Biotechnol; 2005 Sep; 23(9):1046. PubMed ID: 16151387
    [No Abstract]   [Full Text] [Related]  

  • 51. New Zealand launches biotech seed fund.
    Griggs K
    Nat Biotechnol; 2004 Apr; 22(4):480-1. PubMed ID: 15085809
    [No Abstract]   [Full Text] [Related]  

  • 52. Lessons for the nascent regenerative medicine industry from the biotech sector.
    Mason C; Dunnill P
    Regen Med; 2007 Sep; 2(5):753-6. PubMed ID: 17907927
    [No Abstract]   [Full Text] [Related]  

  • 53. Public biotech 2008--the numbers.
    Huggett B; Hodgson J; Lähteenmäki R
    Nat Biotechnol; 2009 Aug; 27(8):710-21. PubMed ID: 19668175
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Biotechnology patents in the food sectors.
    Ramani SV; Malkoc S; Murlis S; van Wesemael KJ
    Nat Biotechnol; 2001 Apr; 19(4):383-4. PubMed ID: 11283600
    [No Abstract]   [Full Text] [Related]  

  • 55. Infotech and biotech: learning the lessons.
    Feachem RG
    Bull World Health Organ; 2001; 79(8):693. PubMed ID: 11545323
    [No Abstract]   [Full Text] [Related]  

  • 56. State of the biotech sector - 2006.
    Lawrence S
    Nat Biotechnol; 2007 Jul; 25(7):706. PubMed ID: 17621283
    [No Abstract]   [Full Text] [Related]  

  • 57. A lifeline for the biotech sector.
    Kessel M
    Nat Biotechnol; 2009 Feb; 27(2):123-4. PubMed ID: 19204686
    [No Abstract]   [Full Text] [Related]  

  • 58. Biotech under Barack.
    Fox JL
    Nat Biotechnol; 2009 Mar; 27(3):237-44. PubMed ID: 19270669
    [No Abstract]   [Full Text] [Related]  

  • 59. Changing patent strategies: what will they mean for the industry?
    Mills AE; Tereskerz PM
    Nat Biotechnol; 2007 Aug; 25(8):867-8. PubMed ID: 17687359
    [No Abstract]   [Full Text] [Related]  

  • 60. [Biotechnology research and generation of patents of interest to the health system].
    Plaza Gómez L; Albert Martínez A
    Med Clin (Barc); 2008 Dec; 131 Suppl 5():55-9. PubMed ID: 19631824
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.